---
title: 'Diagnostic accuracy of Afirma Gene Expression Classifier, Afirma Gene Sequencing
  Classifier, ThyroSeq v2 and ThyroSeq v3 for indeterminate (Bethesda III and IV)
  thyroid nodules: a meta-analysis'
date: '2024-05-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38771544/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240521183404&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: We showed that in patients with ITN, TSv3 has the best
  molecular diagnostic performance, followed by TSv2, GSC, and GEC. For rule-out malignancy,
  GSC, and for rule-in, TSV2 is superior to other ...'
disable_comments: true
---
CONCLUSIONS: We showed that in patients with ITN, TSv3 has the best molecular diagnostic performance, followed by TSv2, GSC, and GEC. For rule-out malignancy, GSC, and for rule-in, TSV2 is superior to other ...